Alvotech (ALVO) Change in Accured Expenses (2021 - 2026)
Alvotech's (ALVO) quarterly Change in Accured Expenses came in at $3.6 million in Q2 2026, down 57.42% on a YoY basis from $8.5 million in Q2 2025, and up 220.01% quarter-over-quarter from -$3.0 million in Q1 2026.
Analysis
Alvotech (ALVO) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Change in Accured Expenses for 6 consecutive years, with $3.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses fell 57.42% year-over-year to $3.6 million; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (up 106.21% YoY), and the FY2025 full-year result was -$2.2 million, up 71.63% from the prior year.
- Change in Accured Expenses climbed to $3.6 million in Q2 2026 per ALVO's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $16.5 million in Q4 2025 and bottomed at -$25.0 million in Q3 2024.
- Historically, Change in Accured Expenses has averaged -$1.0 million across 5 years, with a median of $815500.0 in 2022.
- The widest YoY moves for Change in Accured Expenses: up 353.93% in 2024, down 722.21% in 2024.
- Over 5 years, Change in Accured Expenses stood at $493000.0 in 2022, then jumped by 156.59% to $1.3 million in 2023, then plunged by 722.21% to -$7.9 million in 2024, then surged by 309.48% to $16.5 million in 2025, then tumbled by 78.07% to $3.6 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $3.6 million, -$3.0 million, and $16.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 82.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -111.90 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 66.66 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 73.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 3.62 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.96 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.62 Mn |
| Mar 31, 2026 | -3.01 Mn |
| Dec 31, 2025 | 16.49 Mn |
| Sep 30, 2025 | -14.80 Mn |
| Jun 30, 2025 | 8.49 Mn |
| Mar 31, 2025 | -12.41 Mn |
| Dec 31, 2024 | -7.87 Mn |
| Sep 30, 2024 | -25.04 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 14.54 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Jun 30, 2023 | 471,000.00 |
| Dec 31, 2022 | 493,000.00 |
| Jun 30, 2022 | 1.14 Mn |
| Dec 31, 2021 | -1.16 Mn |
| Sep 30, 2021 | -325,000.00 |